MeSH Review:
Drug Eruptions
- Streptomycin and sulfisoxazole for treatment of Haemophilus influenzae meningitis. Meade, R.H. JAMA (1978)
- Balanitis as a fixed drug eruption to tetracycline. Dodds, P.R., Chi, T.N. J. Urol. (1985)
- Pigmented penile lesions (fixed drug eruptions) associated with tetracycline therapy for sexually transmitted diseases. Fiumara, N.J., Yaqub, M. Sexually transmitted diseases. (1981)
- Severe erythema anulare centrifugum-like psoriatic drug eruption induced by terbinafine. Wach, F., Stolz, W., Hein, R., Landthaler, M. Archives of dermatology. (1995)
- Purpura of the ears: a distinctive vasculopathy with circulating autoantibodies complicating long-term treatment with levamisole in children. Rongioletti, F., Ghio, L., Ginevri, F., Bleidl, D., Rinaldi, S., Edefonti, A., Gambini, C., Rizzoni, G., Rebora, A. Br. J. Dermatol. (1999)
- An expanded profile of cutaneous reactions to nonsteroidal anti-inflammatory drugs. Reports to a specialty-based system for spontaneous reporting of adverse reactions to drugs. Stern, R.S., Bigby, M. JAMA (1984)
- Fixed drug eruption from chlorphenesin carbamate. Coskey, R.J. JAMA (1982)
- Fixed drug eruption and pseudoephedrine. Hauken, M. Ann. Intern. Med. (1994)
- Multilocalized fixed drug eruption to the antihistamine cetirizine. Kränke, B., Kern, T. J. Allergy Clin. Immunol. (2000)
- Successful desensitization of a fixed drug eruption caused by allopurinol. Umpiérrez, A., Cuesta-Herranz, J., De Las Heras, M., Lluch-Bernal, M., Figueredo, E., Sastre, J. J. Allergy Clin. Immunol. (1998)
- Sulfonamide-reactive lymphocytes detected at very low frequency in the peripheral blood of patients with drug-induced eruptions. Kalish, R.S., LaPorte, A., Wood, J.A., Johnson, K.L. J. Allergy Clin. Immunol. (1994)
- Successful desensitization for treatment of a fixed drug eruption to allopurinol. Kelso, J.M., Keating, R.M. J. Allergy Clin. Immunol. (1996)
- Fixed drug eruption induced by mepivacaine. Torres, M.J., Garcia, J.J., del Caño Moratinos, A.M., Rondón, C., Blanca, M. J. Allergy Clin. Immunol. (1995)
- Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and management. Calabrese, J.R., Sullivan, J.R., Bowden, C.L., Suppes, T., Goldberg, J.F., Sachs, G.S., Shelton, M.D., Goodwin, F.K., Frye, M.A., Kusumakar, V. The Journal of clinical psychiatry. (2002)
- Fixed drug eruption associated with co-trimoxazole. Mohamed, K.B. J. Pediatr. (1999)
- Prospective evaluation of risk factors of cutaneous drug reactions to sulfonamides in patients with AIDS. Eliaszewicz, M., Flahault, A., Roujeau, J.C., Fillet, A.M., Challine, D., Mansouri, S., Wolkenstein, P., Aractingi, S., Penso-Assathiany, D., Maslo, C., Bourgault-Villada, I., Chosidow, O., Caumes, E. J. Am. Acad. Dermatol. (2002)
- Pigmented lesions of the tongue in heroin addicts--fixed drug eruption. Westerhof, W., Wolters, E.C., Brookbakker, J.T., Boelen, R.E., Schipper, M.E. Br. J. Dermatol. (1983)
- Fixed drug eruption to mefenamic acid: a report of three cases. Long, C.C., Finlay, A.Y., Marks, R. Br. J. Dermatol. (1992)
- Cutaneous drug eruption from cetirizine and hydroxyzine. Lew, B.L., Haw, C.R., Lee, M.H. J. Am. Acad. Dermatol. (2004)
- Nonpigmenting solitary fixed drug eruption caused by a Chinese traditional herbal medicine, ma huang (Ephedra Hebra), mainly containing pseudoephedrine and ephedrine. Matsumoto, K., Mikoshiba, H., Saida, T. J. Am. Acad. Dermatol. (2003)
- Fixed drug eruption. Expression of epidermal keratinocyte intercellular adhesion molecule-1 (ICAM-1). Shiohara, T., Nickoloff, B.J., Sagawa, Y., Gomi, T., Nagashima, M. Archives of dermatology. (1989)
- Fixed drug eruption of the scrotum due to methylphenidate. Cohen, H.A., Ashkenazi, A., Nussinovitch, M., Gross, S., Frydman, M. The Annals of pharmacotherapy. (1992)
- Immunohistochemical characterization of cutaneous drug eruptions by STI571. Park, H.J., Kim, H.S., Kim, H.J., Lee, J.Y., Cho, B.K., Lee, A.W., Yoon, d.o. .Y., Cho, D.H. J. Dermatol. Sci. (2005)
- Glutathione S-transferase polymorphisms in patients with drug eruption. Ateş, N.A., Tursen, U., Tamer, L., Kanik, A., Derici, E., Ercan, B., Atik, U. Arch. Dermatol. Res. (2004)
- Increased levels of interleukin 5 are associated with the generation of eosinophilia in drug-induced hypersensitivity syndrome. Choquet-Kastylevsky, G., Intrator, L., Chenal, C., Bocquet, H., Revuz, J., Roujeau, J.C. Br. J. Dermatol. (1998)
- Drug eruptions from mesna. After cyclophosphamide treatment of patients with systemic lupus erythematosus and dermatomyositis. Zonzits, E., Aberer, W., Tappeiner, G. Archives of dermatology. (1992)
- Nonpigmenting solitary fixed drug eruption after skin testing and intra-articular injection of triamcinolone acetonide. Sener, O., Caliskaner, Z., Yazicioglu, K., Karaayvaz, M., Ozangüç, N. Ann. Allergy Asthma Immunol. (2001)
- Oral lichen planus and intake of drugs metabolized by polymorphic cytochrome P450 enzymes. Kragelund, C., Thomsen, C.E., Bardow, A., Pedersen, A.M., Nauntofte, B., Reibel, J., Torpet, L.A. Oral diseases. (2003)
- Paracetamol-induced fixed drug eruption with positive immunofluorescence findings. Duhra, P., Porter, D.I. Clin. Exp. Dermatol. (1990)
- Bucillamine-induced toxic epidermal necrolysis and fixed drug eruption. Izumi, A., Katsumi, S., Kobayashi, N., Niizeki, H., Asada, H., Miyagawa, S. J. Dermatol. (2005)